South Africa has begun implementing its plan to give about 180,000 people a fixed-dose combination antiretroviral (ARV) medication, SA Government News Agency reports. Odimune—a generic version of Atripla (emtricitabine/efavirenz/tenofovir)—will be given to people newly diagnosed with HIV, as well as HIV-positive women who are pregnant or breast-feeding. The goal is to reduce the risk of patients failing treatment by lowering the number of pills they need to take daily.

To read the article, click here.